FNY Investment Advisers LLC Invests $414,000 in Nutex Health Inc. $NUTX

Key Points

• FNY Investment Advisers LLC invested $414,000 in Nutex Health Inc. by acquiring 3,333 shares, representing a 0.06% ownership stake as of its latest SEC filing.
• Institutional investment in Nutex Health has increased significantly, with firms like Bank of America and American Century Companies enhancing their stakes by over 6,000% and 73% respectively in recent quarters.
• Analyst ratings for Nutex Health include a "buy" from Maxim Group with a target price of $205.00 and a current average rating of "Moderate Buy" with a consensus price target of $252.50.

FNY Investment Advisers LLC acquired a new position in shares of Nutex Health Inc. (NASDAQ:NUTX - Free Report) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 3,333 shares of the company's stock, valued at approximately $414,000. FNY Investment Advisers LLC owned 0.06% of Nutex Health as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently made changes to their positions in NUTX. Bank of America Corp DE lifted its holdings in shares of Nutex Health by 6,590.3% during the 4th quarter. Bank of America Corp DE now owns 2,074 shares of the company's stock worth $66,000 after acquiring an additional 2,043 shares during the period. Baader Bank Aktiengesellschaft increased its position in shares of Nutex Health by 64.6% during the 1st quarter. Baader Bank Aktiengesellschaft now owns 10,700 shares of the company's stock worth $503,000 after purchasing an additional 4,200 shares in the last quarter. Informed Momentum Co LLC acquired a new stake in shares of Nutex Health during the 1st quarter worth about $868,000. American Century Companies Inc. increased its position in shares of Nutex Health by 73.0% during the 1st quarter. American Century Companies Inc. now owns 74,359 shares of the company's stock worth $3,497,000 after purchasing an additional 31,366 shares in the last quarter. Finally, OMERS ADMINISTRATION Corp increased its position in shares of Nutex Health by 28.8% during the 1st quarter. OMERS ADMINISTRATION Corp now owns 9,400 shares of the company's stock worth $442,000 after purchasing an additional 2,100 shares in the last quarter. 5.32% of the stock is owned by institutional investors.

Nutex Health Trading Down 0.2%

NUTX opened at $114.31 on Thursday. The company has a current ratio of 2.27, a quick ratio of 2.26 and a debt-to-equity ratio of 1.02. The stock has a market capitalization of $635.56 million, a PE ratio of 9.61 and a beta of -0.20. Nutex Health Inc. has a 1-year low of $21.55 and a 1-year high of $184.27. The firm has a 50-day moving average price of $96.42 and a two-hundred day moving average price of $113.70.

Analyst Ratings Changes

NUTX has been the subject of a number of recent analyst reports. Maxim Group set a $205.00 target price on shares of Nutex Health and gave the stock a "buy" rating in a research report on Tuesday, August 26th. Wall Street Zen cut shares of Nutex Health from a "strong-buy" rating to a "buy" rating in a research report on Saturday, October 18th. Finally, Weiss Ratings reiterated a "hold (c-)" rating on shares of Nutex Health in a research report on Wednesday, October 8th. Two research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $252.50.

Nutex Health Profile

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.